Emcure Pharmaceuticals Share price target & analyst calls
₹1,782.6+27.50 (+1.57%)
Avg 1-year target
All 6 long-term calls are BUY₹2,318.3330.1% above today's price
Emcure Pharmaceuticals' average 1-year share price target is ₹2,318.33, the average of 3 advisors' latest targets. Targets range from ₹2,305 to ₹2,330.
Latest: Motilal Oswal ₹2,330 · 21 Oct 2026
6
6 BUY · 0 SELL, all horizons
3
with an active 1Y target
45%
9 of 20 closed calls hit
29
all horizons, open and closed
Watch EMCURE for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
Emcure Pharmaceuticals target price by brokerage
Each advisor's latest 1-year target · 3 advisors · tap a row for the call
All tips (29)
MObyMotilal Oswal+30.7% to target
1 Year* · 12 mo left · 21 Oct 2026 · entry ₹1,755.1 · via Institutional / Brokerage ResearchP&L +1.6%
ISbyICICI Securities+29.3% to target
1 Year* · 11 mo left · 4 Sept 2026 · entry ₹1,927.6 · via Institutional / Brokerage ResearchP&L -7.5%
MObyMotilal Oswal+29.3% to target
1 Year* · 11 mo left · 4 Sept 2026 · entry ₹1,927.6 · via Economic Times New Stock RecosP&L -7.5%
JIbyJefferies India+30.1% to target
1 Year* · 10 mo left · 10 Aug 2026 · entry ₹1,990 · via Financial Express MarketP&L -10.4%
MObyMotilal Oswal+29.0% to target
1 Year* · 10 mo left · 7 Aug 2026 · entry ₹1,936.7 · via Institutional / Brokerage ResearchP&L -8.0%
MObyMotilal Oswal+26.8% to target
1 Year* · 9 mo left · 20 Jul 2026 · entry ₹1,783.2 · via Institutional / Brokerage ResearchP&L -0.0%
JIbyJefferies IndiaTarget hit
1 Year* · 23 Jun 2026 · entry ₹1,791 · via NDTV Profit (Live)exit ₹2,100
BCbyBOB Capital MarketsTarget hit
1 Year* · 6 May 2026 · entry ₹1,659.5 · via Institutional / Brokerage Researchexit ₹1,965
BCbyBOB Capital MarketsTarget hit
1 Year* · 5 Feb 2026 · entry ₹1,482.3 · via Institutional / Brokerage Researchexit ₹1,787
BCbyBOB Capital MarketsTarget hit
1 Year* · 12 Nov 2025 · entry ₹1,337.4 · via Institutional / Brokerage Researchexit ₹1,643
BCbyBOB Capital MarketsTarget hit
1 Year* · 1 Oct 2025 · entry ₹1,304.3 · via Institutional / Brokerage Researchexit ₹1,530
ABbyAkshay Bhagwat, JM FinancialStop-loss hit
1–3 Months · 8 Apr 2026 · entry ₹1,572 · via Business Todayexit ₹1,500
VPbyVaishali Parekh, Prabhudas Lilladher○ No trade
1–3 Months* · 8 Jul 2026 · entry ₹1,700 · via NDTV Profit (Live)
SHbySwati Hotkar, Nirmal Bang Securities○ No trade
1–3 Months · 2 Jun 2026 · entry ₹1,630 · via NDTV Profit (Live)
ICbyIDBI CapitalTarget hit
1–2 Weeks* · 10 Sept 2026 · entry ₹1,954 · via IDBI Capital Research Calls Telegramexit ₹2,090
SRbySahi ResearchTarget hit
1–2 Weeks* · 10 Sept 2026 · entry ₹1,944 · via Sahi Research Telegramexit ₹2,025
KBbyKush BohraStop-loss hit
1–2 Weeks* · 11 Sept 2026 · entry ₹1,965 · via NDTV Profit (Live)exit ₹1,905
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks* · 10 Sept 2026 · entry ₹1,965 · via CNBC Awaaz.exit ₹1,959
NSbyNagaraj Shetty, HDFC SecuritiesStop-loss hit
1–2 Weeks* · 10 Sept 2026 · entry ₹1,963.8 · via NDTV Profit (Live)exit ₹1,900
KBbyKush BohraStop-loss hit
1–2 Weeks* · 10 Aug 2026 · entry ₹2,005 · via NDTV Profit (Live)exit ₹1,915
ABbyAkshay Bhagwat, JM FinancialStop-loss hit
1–2 Weeks* · 25 Mar 2026 · entry ₹1,594.6 · via Business Todayexit ₹1,475
ICbyIDBI CapitalStop-loss hit
Intraday · 1 Oct 2026 · entry ₹1,946 · via IDBI Capital Research Calls Telegramexit ₹1,921
AJbyAnsh Jogendra BhilwarExpired
Intraday · 7 Sept 2026 · entry ₹1,934.8 · via Zee Business (Live)exit ₹1,928.6
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.6% · 19 calls
- CIPLACipla Ltd.₹1,524+14.5% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+26.6% · 15 calls
- BIOCONBiocon Ltd₹485+46.9% · 12 calls
- LUPINLupin Limited₹2,576+34.1% · 12 calls
- EMCURE· this stockEmcure Pharmaceuticals Limited₹2,318+30.1% · 6 calls